Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma

Hyun Soo Kim, Gou Young Kim, Sung Jig Lim, Youn Wha Kim

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods: Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results: Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions: These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.

Original languageEnglish
Pages (from-to)234-242
Number of pages9
JournalKorean Journal of Pathology
Volume44
Issue number3
DOIs
Publication statusPublished - 2010 Jun 1

Fingerprint

Proto-Oncogene Proteins c-raf
Extrahepatic Bile Ducts
Carcinoma
Proteins
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Kim, Hyun Soo ; Kim, Gou Young ; Lim, Sung Jig ; Kim, Youn Wha. / Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma. In: Korean Journal of Pathology. 2010 ; Vol. 44, No. 3. pp. 234-242.
@article{823706c9b5ef48b580b089e500db35e7,
title = "Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma",
abstract = "Background: Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods: Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results: Loss of RKIP expression was observed in 55.0{\%} (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions: These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.",
author = "Kim, {Hyun Soo} and Kim, {Gou Young} and Lim, {Sung Jig} and Kim, {Youn Wha}",
year = "2010",
month = "6",
day = "1",
doi = "10.4132/KoreanJPathol.2010.44.3.234",
language = "English",
volume = "44",
pages = "234--242",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "3",

}

Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma. / Kim, Hyun Soo; Kim, Gou Young; Lim, Sung Jig; Kim, Youn Wha.

In: Korean Journal of Pathology, Vol. 44, No. 3, 01.06.2010, p. 234-242.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma

AU - Kim, Hyun Soo

AU - Kim, Gou Young

AU - Lim, Sung Jig

AU - Kim, Youn Wha

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Background: Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods: Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results: Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions: These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.

AB - Background: Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma. Methods: Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases. Results: Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027). Conclusions: These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=77957355385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957355385&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2010.44.3.234

DO - 10.4132/KoreanJPathol.2010.44.3.234

M3 - Article

AN - SCOPUS:77957355385

VL - 44

SP - 234

EP - 242

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 3

ER -